You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Guidance on the use of imatinib for chronic myeloid leukaemia

  • Technology appraisal guidance
  • Reference number: TA70
  • Published:  22 October 2003
  • Last updated:  21 January 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Leukaemia (chronic myeloid) - imatinib: appendix a-GE decision paper-October 2014

Leukaemia (chronic myeloid) - imatinib: appendix a-GE decision paper-October 2014 Leukaemia (chronic myeloid) - imatinib: appendix a-GE decision paper-October 2014
20 October 2014
(111.04 Kb 32 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 20 October 2014

Back to top